Pedro Paulo Ladeira Júnior
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Pedro Paulo Ladeira Júnior has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Carolina Carvalho Soares Valentim
Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, Kentucky
1 shared publication - Dillan Cunha Amaral
Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
1 shared publication - Elizabet Taylor Pimenta Weba
Faculdade de Medicina, Universidade Estadual da Região Tocantina do Maranhão, Imperatriz, MA, Brazil
1 shared publication Helvécio Neves Feitosa Filho
Faculty of Medicine, Bahiana School of Medicine and Public Health
1 shared publication- Jaime Guedes
Ophthalmology, Glaucoma Research Center, Wills Eye Hospital, Philadelphia, USA
1 shared publication - Kenzo Ogasawara Donato
Department of Medicine, Bahiana School of Medicine and Public Health, Salvador, Brazil
1 shared publication
Latest Publications
- 23 July 2025
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 35 (6) , 2321-2335
Impact of topical insulin as a therapeutic intervention for corneal wounds: A comprehensive systematic review and meta-analysis
Background: Persistent epithelial defects (PEDs) are challenging corneal conditions with prolonged non-healing. Commonly associated with dry eye disease and neurotrophic keratopathy, PEDs can lead to severe complications. Topical insulin has emerged as a therapeutic option, promoting epithelial healing. Methods: We searched Medline, Embase, Web of Science, and Cochrane Library databases following PRISMA guidelines for studies reporting topical insulin for PEDs of any etiology and corneal epithelial defect (CEDs) post-vitrectomy. Healing time, complete wound healing (CWH), epithelization failure (EF), and epithelial healing rate were our analysis outcomes. Statistical analyses employed random-effects models and I² statistic. Results: Thirteen studies involving 390 eyes were included. Mean healing time for all conditions was 20.68 days (95% CI: 11.60, 29.76) with significant heterogeneity. The pooled CWH rate was 94% (95% CI: 0.87, 0.98), with an odds ratio of 5.41 favoring topical insulin over the control group. EF was low at 5% (95% CI: 0, 0.13), and the epithelial healing rate was 0.82 mm²/hour (95% CI: 0.02, 1.62). Subgroup analyses revealed variations. Conclusions: Topical insulin is effective in corneal wound healing, demonstrating high CWH rates and low failure rates. Further well-controlled studies are needed to validate these findings and assess long-term outcomes.
- 23 July 2025
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 35 (6) , 2321-2335
Impact of topical insulin as a therapeutic intervention for corneal wounds: A comprehensive systematic review and meta-analysis
Background: Persistent epithelial defects (PEDs) are challenging corneal conditions with prolonged non-healing. Commonly associated with dry eye disease and neurotrophic keratopathy, PEDs can lead to severe complications. Topical insulin has emerged as a therapeutic option, promoting epithelial healing. Methods: We searched Medline, Embase, Web of Science, and Cochrane Library databases following PRISMA guidelines for studies reporting topical insulin for PEDs of any etiology and corneal epithelial defect (CEDs) post-vitrectomy. Healing time, complete wound healing (CWH), epithelization failure (EF), and epithelial healing rate were our analysis outcomes. Statistical analyses employed random-effects models and I² statistic. Results: Thirteen studies involving 390 eyes were included. Mean healing time for all conditions was 20.68 days (95% CI: 11.60, 29.76) with significant heterogeneity. The pooled CWH rate was 94% (95% CI: 0.87, 0.98), with an odds ratio of 5.41 favoring topical insulin over the control group. EF was low at 5% (95% CI: 0, 0.13), and the epithelial healing rate was 0.82 mm²/hour (95% CI: 0.02, 1.62). Subgroup analyses revealed variations. Conclusions: Topical insulin is effective in corneal wound healing, demonstrating high CWH rates and low failure rates. Further well-controlled studies are needed to validate these findings and assess long-term outcomes.